Article
Lifetime risk of rheumatoid arthritis-associated interstitial lung disease in MUC5B mutation carriers.
Annals of the rheumatic diseases - 1 Dec 2021
Palomäki Antti, Palotie Aarno, Koskela Jukka, Eklund Kari K, Pirinen Matti, Ripatti Samuli, Laitinen Tarja, Mars Nina
Abstract excerpt
OBJECTIVES: To estimate lifetime risk of developing rheumatoid arthritis-associated interstitial lung disease (RA-ILD) with respect to the strongest known risk factor for pulmonary fibrosis, a MUC5B promoter variant. METHODS: FinnGen is a collection of epidemiological cohorts and hospital biobank samples, integrating genetic data with up to 50 years of follow-up within nationwide registries in Finland. Patients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
